# Filing Detail

Form F-4/A - Registration of securities, foreign private issuers, business combinations: [Amend]
SEC Accession No. 0001104659-23-102356
Filing Date
2023-09-20
Accepted
2023-09-20 17:26:20
Documents
21

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | F-4/A | tm2320950-3_f4.htm | F-4/A | 6620927
2 | EXHIBIT 10.1 | tm2320950d4_ex10-1.htm | EX-10.1 | 66062
3 | EXHIBIT 10.6 | tm2320950d4_ex10-6.htm | EX-10.6 | 121802
4 | EXHIBIT 10.7 | tm2320950d4_ex10-7.htm | EX-10.7 | 89136
5 | EXHIBIT 23.1 | tm2320950d4_ex23-1.htm | EX-23.1 | 2801
6 | EXHIBIT 23.2 | tm2320950d4_ex23-2.htm | EX-23.2 | 2416
7 | GRAPHIC | bc_fairness-4clr.jpg | GRAPHIC | 103391
8 | GRAPHIC | fc_chemdraw-bwlr.jpg | GRAPHIC | 121377
9 | GRAPHIC | lg_mnp-4c.jpg | GRAPHIC | 14516
10 | GRAPHIC | lg_psyence-4clr.jpg | GRAPHIC | 43494
11 | GRAPHIC | lg_rnaadvisors-4clr.jpg | GRAPHIC | 54551
12 | GRAPHIC | pc_potential-bw.jpg | GRAPHIC | 130787
13 | GRAPHIC | sg_mnpllp-bw.jpg | GRAPHIC | 8759
14 | GRAPHIC | sg_rnaadvisorsllc-4clr.jpg | GRAPHIC | 21424
15 | GRAPHIC | tb_cancer-bw.jpg | GRAPHIC | 164988
16 | GRAPHIC | tb_disorder-bw.jpg | GRAPHIC | 260583
17 | GRAPHIC | tb_estimate-bw.jpg | GRAPHIC | 219873
18 | GRAPHIC | tb_palliative-bw.jpg | GRAPHIC | 173109
19 | GRAPHIC | tm2320950d4_ex10-1img001.jpg | GRAPHIC | 10519
20 | GRAPHIC | tm2320950d4_ex23-1img001.jpg | GRAPHIC | 3434
21 | GRAPHIC | tm2320950d4_ex23-1img002.jpg | GRAPHIC | 2049
| Complete submission text file | 0001104659-23-102356.txt |  | 8600836

Mailing Address 121 RICHMOND STREET WEST PENTHOUSE SUITE 1300 TORONTO A6 M5H 2K1
Business Address 121 RICHMOND STREET WEST PENTHOUSE SUITE 1300 TORONTO A6 M5H 2K1 27744604171
PSYENCE BIOMEDICAL LTD. (Filer) CIK: 0001985062 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: F-4/A | Act: 33 | File No.: 333-273553 | Film No.: 231267257
SIC: 2834 Pharmaceutical Preparations